Effects of Bone Marrow Mesenchymal Stromal Cell Therapy in Experimental Cutaneous Leishmaniasis in BALB/c Mice Induced by Leishmania amazonensis

Cutaneous leishmaniasis remains both a public health and a therapeutic challenge. To date, no ideal therapy for cutaneous leishmaniasis has been identified, and no universally accepted therapeutic regimen and approved vaccines are available. Due to the mesenchymal stromal cell (MSC) immunomodulatory...

Descripción completa

Detalles Bibliográficos
Autores principales: Pereira, Joyce Carvalho, Ramos, Tadeu Diniz, Silva, Johnatas Dutra, de Mello, Mirian França, Pratti, Juliana Elena Silveira, da Fonseca-Martins, Alessandra Marcia, Firmino-Cruz, Luan, Kitoko, Jamil Zola, Chaves, Suzana Passos, Gomes, Daniel Claudio De Oliveira, Diaz, Bruno Lourenço, Rocco, Patricia R. M., de Matos Guedes, Herbert Leonel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5554126/
https://www.ncbi.nlm.nih.gov/pubmed/28848541
http://dx.doi.org/10.3389/fimmu.2017.00893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5554126/
https://www.ncbi.nlm.nih.gov/pubmed/28848541
http://dx.doi.org/10.3389/fimmu.2017.00893

Ejemplares similares